The Impact of New Data Released at ASH 2022 on the Treatment Landscape of CML and Ph+ ALL

home / insights / the-impact-of-new-data-released-at-ash-2022-on-the-treatment-landscape-of-cml-and-ph-all

Neal Dave, PharmD, and Brandon Dyson, PharmD, BCOP, BCPS, share insights regarding the treatment landscape for patients with CML and Ph+ ALL.

© 2024 MJH Life Sciences

All rights reserved.